Inflation in Turkey has taken an upward turn in July, posing new challenges for the central bank in its efforts to control prices. According to data from Turkstat, the country's statistics office, the consumer price index rose by 47.8% in July compared to the same month last year. This marks a significant acceleration from the 38.2% increase recorded in June.
The surge in inflation brings an end to a period of declining prices in the world's 19th-largest economy. Under the guidance of President Recep Tayyip Erdogan, the central bank has implemented consecutive rate hikes as part of its strategy to combat soaring inflation.
Notably, food prices experienced the sharpest increase in July, rising by 60.7%, as reported by Turkstat. On the other hand, housing costs and clothing & footwear saw a more modest rise. The figures also revealed that core CPI inflation, which excludes the volatile effects of food, energy, alcohol, tobacco, and gold, reached 54.3%.
Clearly, addressing and stabilizing inflation remains a top priority for Turkey's central bank as it grapples with the economic consequences of rising prices.
Related Articles
![General Motors Secures $6 Billion Credit Agreement Amidst UAW Strike](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
General Motors Secures $6 Billion Credit Agreement Amidst UAW Strike
GM secures a $6 billion credit agreement amidst the UAW strike. Quarterly results will be reported soon. Ford and Stellantis also affected by the strike.
![Market Movers Ahead of Monday's Opening](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Market Movers Ahead of Monday's Opening
Get the latest updates on stock gainers and decliners ahead of Monday's opening. Syndax Pharmaceuticals, AMC Entertainment, and Chinese auto makers see signific...
![Processa Pharmaceuticals Shares Slump After Public Offering](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Processa Pharmaceuticals Shares Slump After Public Offering
Shares of Processa Pharmaceuticals decline after public offering pricing. Company expects $7 million in gross proceeds. Stock has fallen 40% since start of year...